BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9583691)

  • 1. Clinical intestinal transplantation: new perspectives and immunologic considerations.
    Abu-Elmagd K; Reyes J; Todo S; Rao A; Lee R; Irish W; Furukawa H; Bueno J; McMichael J; Fawzy AT; Murase N; Demetris J; Rakela J; Fung JJ; Starzl TE
    J Am Coll Surg; 1998 May; 186(5):512-25; discussion 525-7. PubMed ID: 9583691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation.
    Levay-Young B; Gruessner SE; Shearer JD; Cheol Kim S; Nahkleh RE; Gruessner RW
    J Surg Res; 2003 Sep; 114(1):78-89. PubMed ID: 13678702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical intestinal transplantation: a decade of experience at a single center.
    Abu-Elmagd K; Reyes J; Bond G; Mazariegos G; Wu T; Murase N; Sindhi R; Martin D; Colangelo J; Zak M; Janson D; Ezzelarab M; Dvorchik I; Parizhskaya M; Deutsch M; Demetris A; Fung J; Starzl TE
    Ann Surg; 2001 Sep; 234(3):404-16; discussion 416-7. PubMed ID: 11524593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current status of hepatic transplantation at the University of Pittsburgh.
    Abu-Elmagd K; Fung J; Todo S; Rao A; Reyes J; Demetris J; Mazariegos G; Fontes P; McMichael J; Furukawa H
    Clin Transpl; 1995; ():145-70. PubMed ID: 8794262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three years clinical experience with intestinal transplantation.
    Abu-Elmagd K; Todo S; Tzakis A; Reyes J; Nour B; Furukawa H; Fung JJ; Demetris A; Starzl TE
    J Am Coll Surg; 1994 Oct; 179(4):385-400. PubMed ID: 7522850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of liver and gastrointestinal transplantation at the University of Miami.
    Weppler D; Khan R; Fragulidis GP; Nery JR; Ricordi C; Tzakis AG
    Clin Transpl; 1996; ():187-201. PubMed ID: 9286568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow augmentation in kidney transplantation: a large animal study.
    Gruessner RW; Zhang KY; Dunning M; Nakhleh RE; Gruessner AC
    Transpl Int; 2001 Jun; 14(3):159-69. PubMed ID: 11499905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats.
    Murase N; Starzl TE; Tanabe M; Fujisaki S; Miyazawa H; Ye Q; Delaney CP; Fung JJ; Demetris AJ
    Transplantation; 1995 Jul; 60(2):158-71. PubMed ID: 7624958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of intestinal transplantation in children.
    Reyes J; Bueno J; Kocoshis S; Green M; Abu-Elmagd K; Furukawa H; Barksdale EM; Strom S; Fung JJ; Todo S; Irish W; Starzl TE
    J Pediatr Surg; 1998 Feb; 33(2):243-54. PubMed ID: 9498395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome analysis of 71 clinical intestinal transplantations.
    Todo S; Reyes J; Furukawa H; Abu-Elmagd K; Lee RG; Tzakis A; Rao AS; Starzl TE
    Ann Surg; 1995 Sep; 222(3):270-80; discussion 280-2. PubMed ID: 7677458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental short-term immunosuppression after bowel transplantation and donor-specific bone marrow infusion.
    Harmon JV; Gruessner AC; Nakhleh RE; Zhang K; Gruessner RW
    Arch Surg; 2001 Jul; 136(7):817-21. PubMed ID: 11448397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late graft loss and long-term outcome after isolated intestinal transplantation in children.
    Iyer KR; Srinath C; Horslen S; Fox IJ; Shaw BW; Sudan DL; Langnas AN
    J Pediatr Surg; 2002 Feb; 37(2):151-4. PubMed ID: 11819189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges.
    Abu-Elmagd KM; Costa G; Bond GJ; Soltys K; Sindhi R; Wu T; Koritsky DA; Schuster B; Martin L; Cruz RJ; Murase N; Zeevi A; Irish W; Ayyash MO; Matarese L; Humar A; Mazariegos G
    Ann Surg; 2009 Oct; 250(4):567-81. PubMed ID: 19730240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both.
    Murase N; Ye Q; Nalesnik MA; Demetris AJ; Abu-Elmagd K; Reyes J; Ichikawa N; Okuda T; Fung JJ; Starzl TE
    Transplantation; 2000 Dec; 70(11):1632-41. PubMed ID: 11152226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal transplantation in composite visceral grafts or alone.
    Todo S; Tzakis AG; Abu-Elmagd K; Reyes J; Nakamura K; Casavilla A; Selby R; Nour BM; Wright H; Fung JJ
    Ann Surg; 1992 Sep; 216(3):223-33; discussion 233-4. PubMed ID: 1384443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.